Safety and efficacy of hepatitis A vaccine in children with chronic liver disease

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 45

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

258

HTML

2239

Tables (1-5)

195

Sum=2692

Dec 7, 2006 (publication date) through Dec 26, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Dec 7, 2006; 12(45): 7337-7340
Published online Dec 7, 2006. doi: 10.3748/wjg.v12.i45.7337

Table 2 Rate of seroconversion in patients and controls 1 and 6 mo after 1^st dose and 1 mo after 2^nd dose of HA vaccine

Time	Patients(n = 11)	Controls(n = 13)	P
Time	n (%)	n (%)	P
1 mo after the 1^st dose of HA vaccine
Positive	7 (63.6)	13 (100)	0.07
Equivocal	2 (18.2)	0
Negative	2 (18.2)	0
6 mo after the 1^st dose of HA vaccine
Positive	7 (63.6)	13 (100)	0.09
Equivocal	3 (27.3)	0
Negative	1 (9.1)	0
1 mo after the 2^nd (booster) dose of HA vaccine
Positive	11 (100)	13 (100)	0.63
Equivocal	0	0
Negative	0	0

HA: Hepatitis A.

Citation: El-Karaksy HM, El-Hawary MI, El-Koofy NM, El-Sayed R, El-Raziky MAS, Mansour SA, Taha GM, El-Mougy F. Safety and efficacy of hepatitis A vaccine in children with chronic liver disease. World J Gastroenterol 2006; 12(45): 7337-7340
URL: https://www.wjgnet.com/1007-9327/full/v12/i45/7337.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i45.7337